BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 7, 2008
View Archived Issues
Inhibitors of JAK2 V617F mutation developed at SGX Pharmaceuticals
Read More
IMC-3G3 well tolerated in phase I advanced solid tumor study
Read More
AVX-13616 active against Gram-positive, vancomycin-resistant pathogens
Read More
Snapshots of studies of a new fluoroquinolone, finafloxacin
Read More
Pfizer discontinues phase III program for CP-945,598 for weight management
Read More
Salvat submits complete response to FDA approvable letter for Cetraxal
Read More
AEGR-733 phase II data demonstrates significant lowering of LDL cholesterol
Read More
Poniard presents top-line results from phase I oral picoplatin trial
Read More
AnaMar raises funds for chronic joint diseases clinical program
Read More
Bavarian reports successful safety data from phase II Imvamune study
Read More
FDA approves Ranexa for first-line treatment of chronic angina
Read More
Repligen initiates phase IIb RG-2417 study in bipolar disorder
Read More
Recent Dainippon Sumitomo patent discloses new antiinflammatory agents
Read More
Recent Pfizer patent imparts new therapeutic agents for glaucoma
Read More
CEM-101 snapshots: Synthesis, preclinical testing, phase I data
Read More
ConjuChem presents an update on the clinical development of PC-DAC and PC-Insulin
Read More
Canopus granted permission to initiate phase II clinical trial of CB-5300 in HCV
Read More
Sanochemia and Avigen terminate licensing agreement for tolperisone for MS
Read More
NMRC to develop dengue DNA vaccine formulated with Vical's Vaxfectin
Read More
Exelixis and Bristol-Myers extend research agreement for therapies targeted against LXR
Read More
Novel agents for liver diseases reported in recent Nisshin patent
Read More
BTG licenses novel anticancer compound BGC-945 to Onyx
Read More
Phase III study shows Tarceva improves progression-free survival in NSCLC
Read More
WuXi PharmaTech collaborates with Pfizer on ADME assays
Read More
